此次降级反映了Jones Trading的评估，即Anavex当前的股票价值完全取决于欧洲药品管理局 (EMA)即将对阿尔茨海默病药物blarcamesine做出的决定。该申请于2024年12月被接受，人用药品委员会 (CHMP)的意见预计将在2025年11月或12月公布。根据 InvestingPro 分析，该股票目前以8.6倍的市净率交易，相对于其公允价值而言被高估。

Explore top MACD strategies to identify trading entry and exit points. Learn how MACD indicators help predict market momentum ...

Discover the latest bearish signals for Bitcoin and the crypto market. Learn why waiting for a pullback may offer better buy ...

USD/CAD extends its gains for the second successive session, trading around 1.3990 during the early European hours on Friday.

The USD/CAD pair trades marginally higher to near 1.4000 during the European trading session on Tuesday. The Loonie pair ticks up even as the US Dollar (USD) faces selling pressure, indicating ...

Microsoft Corp. (MSFT) shares fell nearly 4% in extended trading after the company disclosed record capital expenditure of ...

The three US indices covered here all look a bit sluggish in the premarket trading session, as we are struggling to find some ...

Slips Below 200-Day EMA (Chart). <li /> The British pound initially rallied on Tuesday but reversed sharply, falling below ...

The US dollar continues to strengthen overall in the early hours of Thursday trading. At this point in time, the greenback ...

Market sentiment is likely to remain favourable for bulls on the Muhurat trading day. Below are some short-term trading ideas ...

USDCHFgained sharply on board-based US dollar buying. Currently trading at 0.80340, it reached an intraday high of 0.80489.

USDCHFpared some of its gains on board-based US dollar selling. Currently trading at 0.79340, it reached a low of 0.79313.